Home » Life & Medical » Global Drugs for Solid Tumors Market Analysis 2016-2020 and Forecast 2021-2026

Global Drugs for Solid Tumors Market Analysis 2016-2020 and Forecast 2021-2026

  94 Pages     Life & Medical  

Available Formats      

Report ID: 72342
Published By: 99Strategy

Summary

The global Drugs for Solid Tumors market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Solid Tumors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Small Molecules

Biologics

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Hoffmann-La Roche

Novartis

Celgene

Johnson & Johnson

Pfizer

BMS

Eli Lilly

GSK

Merck

Sanofi

AbbVie

AstraZeneca

Bayer

Biogen

Boehringer Ingelheim

Boston Biomedical

Daiichi Sankyo

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospitals

Clinics

Academic and Research Institutes

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industry Overview

1.1 Drugs for Solid Tumors Industry

Figure Drugs for Solid Tumors Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Drugs for Solid Tumors

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Drugs for Solid Tumors

1.2.2 Downstream

Table Application Segment of Drugs for Solid Tumors

Table Global Drugs for Solid Tumors Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Drugs for Solid Tumors Market by Type

3.1 By Type

3.1.1 Small Molecules

Table Major Company List of Small Molecules

3.1.2 Biologics

Table Major Company List of Biologics

3.2 Market Size

Table Global Drugs for Solid Tumors Market 2016-2020, by Type, in USD Million

Figure Global Drugs for Solid Tumors Market Growth 2016-2020, by Type, in USD Million

Table Global Drugs for Solid Tumors Market 2016-2020, by Type, in Volume

Figure Global Drugs for Solid Tumors Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Drugs for Solid Tumors Market Forecast 2021-2026, by Type, in USD Million

Table Global Drugs for Solid Tumors Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 Hoffmann-La Roche (Company Profile, Sales Data etc.)

4.1.1 Hoffmann-La Roche Profile

Table Hoffmann-La Roche Overview List

4.1.2 Hoffmann-La Roche Products & Services

4.1.3 Hoffmann-La Roche Business Operation Conditions

Table Business Operation of Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Novartis (Company Profile, Sales Data etc.)

4.2.1 Novartis Profile

Table Novartis Overview List

4.2.2 Novartis Products & Services

4.2.3 Novartis Business Operation Conditions

Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Celgene (Company Profile, Sales Data etc.)

4.3.1 Celgene Profile

Table Celgene Overview List

4.3.2 Celgene Products & Services

4.3.3 Celgene Business Operation Conditions

Table Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Johnson & Johnson (Company Profile, Sales Data etc.)

4.4.1 Johnson & Johnson Profile

Table Johnson & Johnson Overview List

4.4.2 Johnson & Johnson Products & Services

4.4.3 Johnson & Johnson Business Operation Conditions

Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Pfizer (Company Profile, Sales Data etc.)

4.5.1 Pfizer Profile

Table Pfizer Overview List

4.5.2 Pfizer Products & Services

4.5.3 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 BMS (Company Profile, Sales Data etc.)

4.6.1 BMS Profile

Table BMS Overview List

4.6.2 BMS Products & Services

4.6.3 BMS Business Operation Conditions

Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Eli Lilly (Company Profile, Sales Data etc.)

4.7.1 Eli Lilly Profile

Table Eli Lilly Overview List

4.7.2 Eli Lilly Products & Services

4.7.3 Eli Lilly Business Operation Conditions

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 GSK (Company Profile, Sales Data etc.)

4.8.1 GSK Profile

Table GSK Overview List

4.8.2 GSK Products & Services

4.8.3 GSK Business Operation Conditions

Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Merck (Company Profile, Sales Data etc.)

4.9.1 Merck Profile

Table Merck Overview List

4.9.2 Merck Products & Services

4.9.3 Merck Business Operation Conditions

Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Sanofi (Company Profile, Sales Data etc.)

4.10.1 Sanofi Profile

Table Sanofi Overview List

4.10.2 Sanofi Products & Services

4.10.3 Sanofi Business Operation Conditions

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 AbbVie (Company Profile, Sales Data etc.)

4.11.1 AbbVie Profile

Table AbbVie Overview List

4.11.2 AbbVie Products & Services

4.11.3 AbbVie Business Operation Conditions

Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 AstraZeneca (Company Profile, Sales Data etc.)

4.12.1 AstraZeneca Profile

Table AstraZeneca Overview List

4.12.2 AstraZeneca Products & Services

4.12.3 AstraZeneca Business Operation Conditions

Table Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)

4.13 Bayer (Company Profile, Sales Data etc.)

4.13.1 Bayer Profile

Table Bayer Overview List

4.13.2 Bayer Products & Services

4.13.3 Bayer Business Operation Conditions

Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.14 Biogen (Company Profile, Sales Data etc.)

4.14.1 Biogen Profile

Table Biogen Overview List

4.14.2 Biogen Products & Services

4.14.3 Biogen Business Operation Conditions

Table Business Operation of Biogen (Sales Revenue, Cost, Gross Margin)

4.15 Boehringer Ingelheim (Company Profile, Sales Data etc.)

4.15.1 Boehringer Ingelheim Profile

Table Boehringer Ingelheim Overview List

4.15.2 Boehringer Ingelheim Products & Services

4.15.3 Boehringer Ingelheim Business Operation Conditions

Table Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin)

4.16 Boston Biomedical (Company Profile, Sales Data etc.)

4.16.1 Boston Biomedical Profile

Table Boston Biomedical Overview List

4.16.2 Boston Biomedical Products & Services

4.16.3 Boston Biomedical Business Operation Conditions

Table Business Operation of Boston Biomedical (Sales Revenue, Cost, Gross Margin)

4.17 Daiichi Sankyo (Company Profile, Sales Data etc.)

4.17.1 Daiichi Sankyo Profile

Table Daiichi Sankyo Overview List

4.17.2 Daiichi Sankyo Products & Services

4.17.3 Daiichi Sankyo Business Operation Conditions

Table Business Operation of Daiichi Sankyo (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Drugs for Solid Tumors Sales Revenue 2016-2020, by Company, in USD Million

Table Global Drugs for Solid Tumors Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Drugs for Solid Tumors Sales Revenue Share in 2020, by Company, in USD Million

Table Global Drugs for Solid Tumors Sales Volume 2016-2020, by Company, in Volume

Table Global Drugs for Solid Tumors Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Drugs for Solid Tumors Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Drugs for Solid Tumors Market Concentration, in 2020

Figure Europe Drugs for Solid Tumors Market Market Concentration, in 2020

Figure Asia-Pacific Drugs for Solid Tumors MMarket Concentration, in 2020

Figure South America Drugs for Solid Tumors Market Concentration, in 2020

Figure Middle East & Africa Drugs for Solid Tumors Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospitals

Figure Drugs for Solid Tumors Demand in Hospitals, 2016-2020, in USD Million

Figure Drugs for Solid Tumors Demand in Hospitals, 2016-2020, in Volume

6.1.2 Demand in Clinics

Figure Drugs for Solid Tumors Demand in Clinics, 2016-2020, in USD Million

Figure Drugs for Solid Tumors Demand in Clinics, 2016-2020, in Volume

6.1.3 Demand in Academic and Research Institutes

Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2016-2020, in USD Million

Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Drugs for Solid Tumors Demand Forecast 2021-2026, by Application, in USD Million

Figure Drugs for Solid Tumors Market Growth 2021-2026, by Application, in USD Million

Figure Drugs for Solid Tumors Market Share in 2026, by Application, in USD Million

Table Drugs for Solid Tumors Demand Forecast 2021-2026, by Application, in Volume

Table Drugs for Solid Tumors Market Growth 2021-2026, by Application, in Volume

Table Drugs for Solid Tumors Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Drugs for Solid Tumors Production 2016-2020, by Region, in USD Million

Table Drugs for Solid Tumors Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Drugs for Solid Tumors Market 2016-2020, by Region, in USD Million

Table Global Drugs for Solid Tumors Market Share 2016-2020, by Region, in USD Million

Table Global Drugs for Solid Tumors Market 2016-2020, by Region, in Volume

Table Global Drugs for Solid Tumors Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

Figure North America Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

Table North America Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

Figure Europe Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

Table Europe Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

Figure South America Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

Table South America Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Drugs for Solid Tumors Market Forecast 2021-2026, by Region, in USD Million

Table Drugs for Solid Tumors Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

1. Table Upstream Segment of Drugs for Solid Tumors

2. Table Application Segment of Drugs for Solid Tumors

3. Table Global Drugs for Solid Tumors Market 2016-2026, by Application, in USD Million

4. Table Major Company List of Biologics

5. Table Global Drugs for Solid Tumors Market 2016-2020, by Type, in USD Million

6. Table Global Drugs for Solid Tumors Market 2016-2020, by Type, in Volume

7. Table Global Drugs for Solid Tumors Market Forecast 2021-2026, by Type, in USD Million

8. Table Global Drugs for Solid Tumors Market Forecast 2021-2026, by Type, in Volume

9. Table Hoffmann-La Roche Overview List

10. Table Business Operation of Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

11. Table Novartis Overview List

12. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

13. Table Celgene Overview List

14. Table Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

15. Table Johnson & Johnson Overview List

16. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

17. Table Pfizer Overview List

18. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

19. Table BMS Overview List

20. Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

21. Table Eli Lilly Overview List

22. Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

23. Table GSK Overview List

24. Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

25. Table Merck Overview List

26. Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

27. Table Sanofi Overview List

28. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

29. Table AbbVie Overview List

30. Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

31. Table AstraZeneca Overview List

32. Table Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)

33. Table Bayer Overview List

34. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

35. Table Biogen Overview List

36. Table Business Operation of Biogen (Sales Revenue, Cost, Gross Margin)

37. Table Boehringer Ingelheim Overview List

38. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin)

39. Table Boston Biomedical Overview List

40. Table Business Operation of Boston Biomedical (Sales Revenue, Cost, Gross Margin)

41. Table Daiichi Sankyo Overview List

42. Table Business Operation of Daiichi Sankyo (Sales Revenue, Cost, Gross Margin)

43. Table Global Drugs for Solid Tumors Sales Revenue 2016-2020, by Company, in USD Million

44. Table Global Drugs for Solid Tumors Sales Revenue Share 2016-2020, by Company, in USD Million

45. Table Global Drugs for Solid Tumors Sales Volume 2016-2020, by Company, in Volume

46. Table Global Drugs for Solid Tumors Sales Volume Share 2016-2020, by Company, in Volume

47. Table Regional Demand Comparison List

48. Table Major Application in Different Regions

49. Table Drugs for Solid Tumors Demand Forecast 2021-2026, by Application, in USD Million

50. Table Drugs for Solid Tumors Demand Forecast 2021-2026, by Application, in Volume

51. Table Drugs for Solid Tumors Market Growth 2021-2026, by Application, in Volume

52. Table Drugs for Solid Tumors Market Share in 2026, by Application, in Volume

53. Table Drugs for Solid Tumors Production 2016-2020, by Region, in USD Million

54. Table Drugs for Solid Tumors Production 2016-2020, by Region, in Volume

55. Table Global Drugs for Solid Tumors Market 2016-2020, by Region, in USD Million

56. Table Global Drugs for Solid Tumors Market Share 2016-2020, by Region, in USD Million

57. Table Global Drugs for Solid Tumors Market 2016-2020, by Region, in Volume

58. Table Global Drugs for Solid Tumors Market Share 2016-2020, by Region, in Volume

59. Table North America Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

60. Table North America Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

61. Table Europe Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

62. Table Europe Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

63. Table Asia-Pacific Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

64. Table Asia-Pacific Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

65. Table South America Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

66. Table South America Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

67. Table Middle East & Africa Drugs for Solid Tumors Market Size 2016-2020, by Country, in USD Million

68. Table Middle East & Africa Drugs for Solid Tumors Market Size 2016-2020, by Country, in Volume

69. Table Drugs for Solid Tumors Market Forecast 2021-2026, by Region, in USD Million

70. Table Drugs for Solid Tumors Market Forecast 2021-2026, by Region, in Volume

71. Table Price Factors List

List of Figure

List of Figure

1. Figure Drugs for Solid Tumors Industry Chain Structure

2. Figure Global Drugs for Solid Tumors Market Growth 2016-2020, by Type, in USD Million

3. Figure Global Drugs for Solid Tumors Market Growth 2016-2020, by Type, in Volume

4. Figure Global Drugs for Solid Tumors Sales Revenue Share in 2020, by Company, in USD Million

5. Figure Global Drugs for Solid Tumors Sales Volume Share in 2020, by Company, in Volume

6. Figure North America Drugs for Solid Tumors Market Concentration, in 2020

7. Figure Europe Drugs for Solid Tumors Market Market Concentration, in 2020

8. Figure Asia-Pacific Drugs for Solid Tumors MMarket Concentration, in 2020

9. Figure South America Drugs for Solid Tumors Market Concentration, in 2020

10. Figure Middle East & Africa Drugs for Solid Tumors Market Concentration, in 2020

11. Figure Drugs for Solid Tumors Demand in Hospitals, 2016-2020, in USD Million

12. Figure Drugs for Solid Tumors Demand in Hospitals, 2016-2020, in Volume

13. Figure Drugs for Solid Tumors Demand in Clinics, 2016-2020, in USD Million

14. Figure Drugs for Solid Tumors Demand in Clinics, 2016-2020, in Volume

15. Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2016-2020, in USD Million

16. Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2016-2020, in Volume

17. Figure Drugs for Solid Tumors Market Growth 2021-2026, by Application, in USD Million

18. Figure Drugs for Solid Tumors Market Share in 2026, by Application, in USD Million

19. Figure North America Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

20. Figure North America Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

21. Figure Europe Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

22. Figure Europe Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

23. Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

24. Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

25. Figure South America Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

26. Figure South America Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

27. Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2016-2020, in USD Million

28. Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2016-2020, in Volume

29. Figure Marketing Channels Overview

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020